Run Tan (润坦)润坦
This is a medicine registration record from NMPA data.本页为国家药监局药品注册记录。
Labeled sections from the recorded Chinese source are included below. English wording is a reference translation when one is on file, not an official English label.本记录未接入产品级适应症/安全性标注字段。
生产企业Manufacturer
- 河南润弘制药股份有限公司Chinese legal name: 河南润弘制药股份有限公司
主要成分Active Ingredients
- 长春西汀Changchun Xiting
药物知识说明
长春西汀是一种在国家药监局注册认定的药品。标注生产企业为河南润弘制药股份有限公司。
该药品暂无关联的活性成分信息。
该药品标注的生产企业为：河南润弘制药股份有限公司Chinese legal name: 河南润弘制药股份有限公司、河南润弘制药股份有限公司Chinese legal name: 河南润弘制药股份有限公司、河南润弘制药股份有限公司Chinese legal name: 河南润弘制药股份有限公司。
本页面内容来自国家药监局数据库，MedicineGraph在此基础上提供关系图谱和知识导航。
Medicine Knowledge
This medicine (original name: 润坦) is a medicine registered with the national drug regulatory authority. It is manufactured by Chinese legal name: 河南润弘制药股份有限公司.
No active ingredient relationships are currently recorded for this product in MedicineGraph.
Manufacturers recorded for this product: 河南润弘制药股份有限公司Chinese legal name: 河南润弘制药股份有限公司, 河南润弘制药股份有限公司Chinese legal name: 河南润弘制药股份有限公司, 河南润弘制药股份有限公司Chinese legal name: 河南润弘制药股份有限公司.
Source: MedicineGraph authoritative database. Relationships derived from registered product information.
这是什么What is this
- 通用名/品名Recorded product name: 润坦Recorded Chinese name: 润坦
- 剂型Dosage form: 注射剂Injection
- 规格Specification: 2ml:20mg2 mL:20 mg
本段仅展示注册/说明书已记录的身份属性，不含适应症或用法建议。Identity attributes from registration/leaflet records only; no indications or usage advice.
生产企业Manufacturer
- 河南润弘制药股份有限公司Chinese legal name: 河南润弘制药股份有限公司
注册信息NMPA approval number
- 批准文号NMPA approval number: 国药准字H20010467
关联实体Relationships
信息来源Source and scope
国家药品监督管理局（中国）药品注册数据及已接入说明书字段。National Medical Products Administration (China) medicine-registration data and linked leaflet fields.
- 品名来源Name source: 10多万条药品说明书数据库 (HIGH)Package-insert database (more than 100,000 records) (HIGH)
- 生产企业来源Manufacturer source: 10多万条药品说明书数据库Package-insert database (more than 100,000 records)
- 剂型来源Dosage-form source: 10多万条药品说明书数据库Package-insert database (more than 100,000 records)
范围：当前 MedicineGraph 注册记录及已记录的精确关系；非完整目录，亦不构成疗效等同主张，也不支持换用判断。不含适应症/安全性推断。Scope: current MedicineGraph registration records and exact recorded relationships; not a complete catalog and not a claim of therapeutic equivalence. No inferred indications/safety.
本段为已核准说明书原文摘录（非改写、非AI摘要），非正式英文标签，亦不构成用药建议。 Not an official English label and not medical advice. English wording, when shown, is a reference translation of the Chinese source label.
English translation for reference. Translated from the Chinese source label. Not an official English label and not medical advice.
NMPA approval number
国药准字H20010467
Manufacturer
Chinese legal name: 河南润弘制药股份有限公司 (domestically manufactured)
Indications
English translation unavailable. The original Chinese source label remains available below.
Dosage and administration
English translation unavailable. The original Chinese source label remains available below.
Adverse reactions
English translation unavailable. The original Chinese source label remains available below.
Contraindications
English translation unavailable. The original Chinese source label remains available below.
Precautions
English translation unavailable. The original Chinese source label remains available below.
Storage
English translation unavailable. The original Chinese source label remains available below.
Specification
English translation unavailable. The original Chinese source label remains available below.
中文说明书原文Original Chinese source label
批准文号
国药准字H20010467
生产企业
河南润弘制药股份有限公司(国产)
适应症
改善脑梗塞后遗症、脑出血后遗症、脑动脉硬化症等诱发的各种症状。
用法用量
静脉滴注，开始剂量每天20mg,以后根据病情可增至每天30mg。可用本品20-30mg加入500ml液体内，缓慢滴注。
不良反应
尚不明确。
禁忌
1.对本品过敏者禁用； 2.颅内出血后尚未完全止血者禁用； 3.严重缺血性心脏病、严重心律失常者禁用。 4.本品含苯甲醇，禁止用于儿童肌肉注射。
注意事项
1.本品不可静脉或肌内推注。 2.输液中长春西汀含量不得超过0.06mg/ml，否则有溶血的可能。 3.本品含山梨醇，糖尿病病人应用时注意。
贮藏
遮光，密闭，在阴凉处（不超过20℃）保存。
规格
2ml:20mg
信息来源Source and scope
国家药品监督管理局（中国）药品注册数据。National Medical Products Administration (China) medicine-registration data.
范围：当前 MedicineGraph 注册记录及已记录的精确关系；非完整目录，亦不构成疗效等同主张，也不支持换用判断。Scope: current MedicineGraph registration records and exact recorded relationships; not a complete catalog and not a claim of therapeutic equivalence.